This administrative amendment introduces no new financial information or catalysts. Monitor the next quarterly filing for any operational updates under the new CEO, Trent Green.
Price Chart
Executive Summary
NRC Health filed an amended 10-K (Amendment No. 1) solely to provide Part III information—director/officer details, executive compensation, beneficial ownership, and auditor fees—that was omitted from the original 10-K because the proxy statement was not filed within 120 days. The amendment does not restate or modify any financial statements and contains no material changes to the company's financial position or results.
Key Facts
- Amendment adds Items 10–14 (directors, executive compensation, security ownership, related transactions, auditor fees) not included in the original 10-K filed March 5, 2026.
- No financial statements, restatements, or changes to prior disclosures are included in this amendment.
- CEO Trent Green received total compensation of $11,961,900 in 2025, including a $6.755 million stock award and $4.503 million bonus.
- Founder Michael Hays, former CEO, received $184,416 in 2025 and holds 3.8% beneficial ownership; Patrick Beans beneficially owns 46.9% through related trusts.
- KPMG LLP served as auditor; total fees were $847,175 for 2025, up from $788,417 in 2024.
Financial Impact
Not specified
Risk Factors
- No material risks disclosed beyond those in the original 10-K.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 10-K/A Filing (Primary) | 0001437749-26-013686 |
| Exhibit: ex_950760.htm | 0001437749-26-013686 |
| Exhibit: ex_950761.htm | 0001437749-26-013686 |
| Document: 0001437749-26-013686-index-headers.html | 0001437749-26-013686 |
| Document: 0001437749-26-013686-index.html | 0001437749-26-013686 |
| Document: 0001437749-26-013686.txt | 0001437749-26-013686 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $22.45 | awaiting T+60 | — | $21.75 (−3.12%) |
Oct 19, 2026 8d ago | 8-K | $20.47 | awaiting T+60 | — | $21.75 (+6.25%) |
Apr 28, 2026 26w ago | 10-K/A | $16.54 $21.04 | ▲ +27.21% | ▲ +23.10% | $21.75 (+31.50%) |
Apr 28, 2026 26w ago | 8-K | $16.54 $21.04 | ▲ +27.21% | ▲ +23.10% | $21.75 (+31.50%) |
Apr 20, 2026 27w ago | 8-K | $17.18 $21.94 | ▲ +27.71% | ▲ +20.81% | $21.75 (+26.60%) |
Mar 5, 2026 33w ago | 8-K | $13.91 $20.25 | ▲ +45.56% | ▲ +34.26% | $21.75 (+56.34%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers